N0001923F2517↗
The Boeing Company received this contract from Naval Air Systems Command, Department of the Navy: $27.73M obligated so far for national defense r&d services; department of defense - military; experimental development. It runs to 2027-04-30.
Key facts · data as of Oct 25, 2026
- Recipient
- The Boeing Company
- Awarding agency
- Department of the Navy (Department of Defense)
- Contracting office
- Naval Air Systems Command (N00019)
- Obligated to date
- $27.73M
- Potential value
- $29.83M
- Ends
- 2027-04-30
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award N0001923F2517, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_N0001923F2517_9700_N0001922D0007_9700
The Boeing Company: all federal awards · Department of Defense: spending · Naval Air Systems Command: what it buys · The follow-on: recompete brief
AUTODICASS + ACOMMS STUDY
Up for re-bid: ends 2027-04-30. Recompete brief → · Engineering and technical support for AN/APG-65 and AN/APG-79 Active Electronically Scanned Array (AESA) radars ↗
What it is
- Product or service
- National Defense R&D Services; Department of Defense - Military; Experimental Development (PSC AC13)
- Industry
- Aircraft Manufacturing (NAICS 336411)
- Contracting office
- Naval Air Systems Command (N00019)
- Competition
- Not available for competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under N0001922D0007
- Solicitation
- N0001921R0052
- Where the work is
- Orange, CA · district CA-47
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
25 actions since 2023-02-16. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-02 | P00024 | Funding only | $350.0K | INCREMENTAL FUNDING CLIN 0002 |
| 2026-05-07 | P00023 | Supplemental agreement (work within scope) | $3.17M | COST POP EXTENSION |
| 2026-03-06 | P00022 | Funding only | $564.2K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. INCREMENTALLY FUND CLIN 0002 VIA SLIN 000225 IN THE AMOUNT OF $564,155.86 2. UPDATE ALLOTMENT OF FUNDS CLAUSES HTXT.232-9524 AND HTXT.232-9516 ACCORDINGLY |
| 2025-12-09 | P00021 | Funding only | $3.23M | INCREMENTAL FUNDING |
| 2025-09-30 | P00020 | Funding only | $500.0K | INCREMENTAL FUNDING |
| 2025-09-19 | P00019 | Funding only | $500.0K | INCREMENTAL FUNDING |
| 2025-07-31 | P00018 | Funding only | $1.11M | INCREMENTAL FUNDING |
| 2025-05-07 | P00017 | Funding only | $2.67M | INCREMENTAL FUNDING ON CLIN 0002 |
| 2025-04-09 | P00016 | Funding only | $821.7K | INCREMENTALLY FUND CLIN 0002 |
| 2025-03-18 | P00015 | Funding only | $643.3K | INCREMENTALLY FUND CLIN 0002 AND 0004 |
| 2024-12-19 | P00014 | Funding only | $2.03M | INCREMENTAL FUNDING |
| 2024-10-31 | P00013 | Option exercised | $499.3K | EXERCISE OPTION ON CLIN 0004 AND PROVIDE INCREMENTAL FUNDING FOR THIS CLIN IN THE AMOUNT OF $499,252.11 |
| 2024-09-10 | P00012 | Supplemental agreement (work within scope) | $34.1K | ADD 53H CAPABILITY, WITH A COST INCREASE OF $34,100.00. |
| 2024-08-22 | P00011 | Change order | $2.82M | INCORPORATE THE INCREASE OF SCOPE, INCREASE THE CEILING OF CLIN 0002, EXTEND THE PERIOD OF PERFORMANCE OF CLIN 0002 AND 0003, INCREMENTALLY FUND CLIN 0002, ADD OPTION CLIN 0004, |
| 2024-05-30 | P00010 | Funding only | $2.06M | INCREMENTAL FUNDING |
| 2024-04-23 | P00009 | Supplemental agreement (work within scope) | $183.0K | INC CEILING AND FUNDING ON CLIN 0002 EXTEND POP |
| 2024-04-05 | P00008 | Funding only | $325.5K | INCREMENTALLY FUND CLIN 0002 VIA SLIN 000208 FOR $325,467.62 EXTEND POP FOR CLIN 0002 AND 0003 THROUGH 9 MAY 2024 |
| 2024-03-19 | P00007 | Administrative change | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE ADMINISTRATIVE CODE IN BLOCK 7. |
| 2024-03-14 | P00006 | Funding only | $365.5K | INCREMENTAL FUNDING AND PERIOD OF PERFORMANCE EXTENSION |
| 2024-02-13 | P00005 | Change order | $609.0K | SCOPE INCREASE ON CLIN 0002 PER UPDATED PWS IN SECTION J |
| 2023-12-20 | P00004 | Funding only | $531.5K | INCREMENTAL FUNDING |
| 2023-10-25 | P00003 | Funding only | $750.0K | INCREMENTALLY FUND CLIN 0002 $750,000.00 VIA SLIN 000204 |
| 2023-09-11 | P00002 | Funding only | $253.5K | THE PURPOSE OF THIS MOD IS TO ADD INCREMENTAL FUNDING TO CLIN 002 IN THE AMOUNT OF $181,546.25. |
| 2023-07-17 | P00001 | Administrative change | $0 | EXTEND THE END DATE FOR INCREMENTAL FUNDING CLAUSES 5252.232-9516 AND 5252.232-9524 FROM 1 JULY 2023 TO 30 NOVEMBER 2023 AND ADMINISTRATIVELY UPDATE SECTION J. |
| 2023-02-16 | 0 | $3.70M | AUTODICASS + ACOMMS STUDY |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗